Table: Pharmarise Holdings -2017/18 group results

Pharmarise Holdings

24/07/2018 09:30

Jul 24 (Reuters)- 
          Pharmarise Holdings Corp 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT    
                May 31, 2018    May 31, 2017   May 31, 2019     YEAR      
                   LATEST         YEAR-AGO        COMPANY       COMPANY   
                   RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales             54.56           52.95          52.50         25.70    
                 (+3.0 pct)      (+9.1 pct)     (-3.8 pct)    (-5.6 pct)  
  Operating          1.18          442 mln        395 mln       18 mln    
                (+166.3 pct)     (-45.5 pct)    (-66.5 pct)   (-96.9 pct) 
  Recurring          1.09          324 mln        270 mln     loss 39 mln 
                (+236.9 pct)     (-50.8 pct)    (-75.3 pct)               
  Net
  Net            loss 28 mln        7 mln      loss 205 mln  loss 220 mln 
                                 (-98.0 pct)                              
  EPS           loss 3.19 yen     0.85 yen                                
  EPS Diluted                     0.83 yen                                
  Ann Div         14.00 yen       14.00 yen      14.00 yen                
  -Q2 Div            NIL             NIL            NIL                   
  -Q4 Div         14.00 yen       14.00 yen      14.00 yen                
  
  NOTE - Pharmarise Holdings Corp.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T